NSPR Message Board Post 10581320 | InspireMD Inc.
home / stock / nspr / nspr message board
(investorshangout)
Posted on: Oct/13/2021 13:50:49
Source: investorshangout
https://investorshangout.com/post/view?id=6261514
whytestocks: $NSPR News Article - InspireMD Receives Reimbursement Approval for CGuard(TM) Embolic Prevention Sys
News, Short Squeeze, Breakout and More Instantly...
-
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...
-
- Generated first quarter 2024 CGuard EPS revenue of $1.51 million, an increase of 22.0% over the first quarter of 2023 - - Announced that an abstract detailing one-year outcomes from the C-GUARDIANS IDE clinical trial of CGuard™ Prime has been accepted for presentation at LINC 2...